Light Treatment for Sleep Disorders: Consensus Report
- 1 June 1995
- journal article
- research article
- Published by SAGE Publications in Journal of Biological Rhythms
- Vol. 10 (2), 113-125
- https://doi.org/10.1177/074873049501000204
Abstract
The rationale for the treatment of sleep disorders by scheduled exposure to bright light in seasonal affective disorder, jet lag, shift work, delayed sleep phase syndrome, and the elderly is, in part, based on a conceptual framework developed by nonclinical circadian rhythm researchers working with humans and other species. Some of the behavioral and physiological data that contributed to these concepts are reviewed, and some pitfalls related to their application to bright light treatment of sleep disorders are discussed. In humans and other mammals the daily light-dark (LD) cycle is a major synchronizer responsible for entrainment of circadian rhythms to the 24-h day, and phase response curves (PRCs) to light have been obtained. In humans, phase delays can be induced by light exposure scheduled before the minimum of the endogenous circadian rhythm of core body temperature (CBT), whereas phase advances are induced when light exposure is scheduled after the minimum of CBT. Since in healthy young subjects the minimum of CBT is located approximately 1 to 2 h before the habitual time of awakening, the most sensitive phase of the PRC to light coincides with sleep, and the timing of the monophasic sleep-wake cycle itself is a major determinant of light input to the pacemaker. The effects of light are mediated by the retinohypothalamic tract, and excitatory amino acids play a key role in the transduction of light information to the suprachiasmatic nuclei. LD cycles have direct "masking" effects on many variables, including sleep, which complicates the assessment of endogenous circadian phase and the interpretation of the effects of light treatment on sleep disorders. In some rodents motor activity has been shown to affect circadian phase, but in humans the evidence for such a feedback of activity on the pacemaker is still preliminary. The endogenous circadian pacemaker is a major determinant of sleep propensity and sleep structure; these, however, are also strongly influenced by the prior history of sleep and wakefulness. In healthy young subjects, light exposure schedules that do not curtail sleep but induce moderate shifts of endogenous circadian phase have been shown to influence the timing of sleep and wakefulness without markedly affecting sleep structure.Keywords
This publication has 131 references indexed in Scilit:
- GABA is the principal neurotransmitter of the circadian systemNeuroscience Letters, 1993
- Aging young sleep: a test of the phase advance hypothesis of sleep disturbance in the elderlyJournal of Sleep Research, 1992
- Effect of Constant Light, Pinealectomy and Guanosine Triphosphate Gamma‐S on the Density of Melatonin Receptors in the Rat Suprachiasmatic Nucleus: A Possible Implication of Melatonin ActionJournal of Neuroendocrinology, 1992
- Photic induction of Fos protein in the suprachiasmatic nucleus is inhibited by the NMDA receptor antagonist MK-801Neuroscience Letters, 1991
- Circadian rhythms and bright light: Recommendations for shift workWork & Stress, 1990
- Exposure to Bright Light and Darkness to Treat Physiologic Maladaptation to Night WorkNew England Journal of Medicine, 1990
- Melatonin stabilises sleep onset time in a blind man without entrainment of cortisol or temperature rhythmsNeuroscience Letters, 1990
- Phase-dependent shift of free-running human circadian rhythms in response to a single bright pulseCellular and Molecular Life Sciences, 1987
- A Circadian Pacemaker for Visual Sensitivity?aAnnals of the New York Academy of Sciences, 1985
- Effects of Illumination on Suprachiasmatic Nucleus Electrical DischargeaAnnals of the New York Academy of Sciences, 1985